Upload
others
View
0
Download
0
Embed Size (px)
Citation preview
Management of highly pathogenic infectious diseases
in Europe:A European Network survey
by EuroNIHDPr Philippe BROUQUI
Emerging Infectious and Tropical Diseases Research UnitUHI of Infectious and Tropical Disease Marseille
URMITE CNRS/IRD UMR 6236/198EURONHID
Financial Disclosures: None ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Problems posed by HP agents• Highly pathogenic agent / Highly Infectious disease
• EUNID defines a highly infectious disease as an infection that is transmissible from person to person; is life threatening; presents a serious hazard in the health‐care setting and the community; and requires specific control measures – Known or yet unknown agent equivalent to class 3 and 4 agent but
H to H transmissible• Ex : It does not include most vector‐borne agent but includes pandemic
influenza
– Propitiously causing hospital acquired and population life threatening outbreaks
– Usually detected first in health care setting outbreaks and further as laboratory acquired accident.
2
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Example of HPA
3
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Eunid /EuroNHID• EC funded European Networks for
Highly Infectious Diseases.– To define recommendation for
optimal management of patients with HID based upon literature (Eunid).
• No evidence based features
– To investigate the appropriateness between recommendations and observation in a field‐study of official European referral centers for care of HID (EuroNHID)
• Survey 16 countries– 47 referral centers
– Check lists based upon our recommendation
4
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Eunid recommendations
• Published in two companion papers in the Lancet Infectious disease– Design and operation of HLIU
• Location, connection, technical features, access to diagnostic laboratory, autoclaving….
– Management of patient with a HID• At the emergency department, isolation, laboratory sampling, endoscopy, Imaging…. Necropsy
5
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
6
Isolation units HLIU
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Patient management a ED
7
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
8
Imaging and dialysis
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
9
Pediatrics and IC practice
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
10
Invasive procedures
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
POST Mortem examination
11
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
HLIU in Europe
The Euro‐HNID Survey
(F Fusco)
12
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
HLIU:Hopital Spallanzani Rome“10 NSB4 Isolation Rooms / 35 Quarantine rooms”
One BSL4 and 2 BSL3 integrated diagnostic laboratories
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
HLIU Marseille BSL3 (2005) (6 rooms with ICU)
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Marseille France HLIU • Built as a BSL3 laboratory replacing hoods by beds
15
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
London Royal Free Hospital Isolator
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Nancy France HLIU ( 4 beds)
• 4 isolation bed rooms in BSL3 at the infectious disease outpatient unit – dedicated entrance
17
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
MILAN Italy (Lugi Sacco)
• HID patient admission in a separate ID emergency unit close to the ED of the hospital
• HCW specifically trained
• Transfer to ID wards
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
MILAN Italy
• # 90 one bed room 3 floors– independent negative
pressure
– including 20 in BSL”2/3”
– BSL2/3 imaging room
• # 100 Chronic post infectious beds in another closely located building
• Specifically trained team
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Milan Italy
• BSL3 Necropsy room located within the hospital– Working routinely
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
# 200 pages Manual for safe management of HID21
Euro NHID survey results
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Chapter 2 – MEDICAL ISSUESS. Schilling (Germany)
22
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Chapter 3 ‐ PERSONNEL MANAGEMENTS. Schilling (Germany)
A: A special shift plan to be used in the case of HID patients that consider all of explored items is available.
B: A special shift plan to be used in the case of HID patients is not available, but some of the explored items are available to address these specific needs.
C: A special shift plan to be used in the case of HID patient/s does not exist, and explored items are not available to address these specific needs.
23
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Chapter 4 – MANAGEMENT OF DIAGNOSTIC PROCEDURES
P Brouqui (France)
– 81% of the surveyed isolation facilities throughout Europe are located nearby a BSL3 lab
– 19 % the referral centres, which do not have such lab facilities, protocols for secure handling of sample are available.
24
38; 81%
9; 19%
0; 0%
A
B
C
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Where are performed microbiological and routine
diagnostic test ?
• Recommendation for sampling– Sampling HID patients for laboratory analysis should be performed in the
isolation room of the ED or in the Isolation Unit following written protocols
– Should use if possible bedside laboratory test analysis (ex malaria test)
25
7
31
18
5
05
101520253035
Inside the isolation area
(same room or other room)
In the BSL-3 reference lab
In the general lab, with closed-
type authomatized
analysers
In the general lab, without use of closed-type authomatized
analysers
Appropriate location and procedures for microbiological test
1215
26
15
05
1015202530
Inside the isolation area
(same room or other room)
In the BSL-3 reference lab
In the general lab, with closed-
type authomatized
analysers
In the general lab, without use of closed-type authomatized
analysers
Appropriate location and procedures for routine tests
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Chap 5 ‐ EMERGENCY DEPTF Fusco (Italia)
A: The Emergency Department associated with isolation facility is equipped with a single room (ideally with negative pressure) for isolation with a direct access and a dedicated route
B: The Emergency Department associated with isolation facility has a specific area for isolation, but without specific technical/logistic features
C: The Emergency Department associated with isolation facility has not a specific area for isolation
26
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Chap 5 ‐ EMERGENCY DEPTF Fusco (Italia)
A: The Emergency Department has all the structural/logistic features and procedures for the limiting of spreading of Infectious Diseases
B: The Emergency Department has partially adequate structural/logistic features and procedures (at least 3 explored items in place)
C: The Emergency Department has not adequate structural/logistic features and procedures (less than 3 explored items in place)
27
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Chap 5 ‐ EMERGENCY DEPTF Fusco (Italia)
A: A specifically trained triage HCWs is available on 24h‐basis
B: A specifically trained triage HCWs is available, but not on 24h‐basis
C: A specifically trained triage HCWs is not available
28
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Chapter 11 – WASTE MANAGEMENT
29
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
How Does this impacted the management of the last
pandemic ?
30
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Distribution of 2009 Flu patients in Marseilles university referral center
hospital
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Hospital acquired Influenza in HCP
0
50
100
150
200
250
0
5
10
15
20
43 44 45 46 47 48 49 50 51 52 53 1Pediatric Dpt Ped emerg Dpt.Adult emerg Dpt. Adult medicine DptESCMID
Onli
ne Le
cture
Librar
y
© by au
thor
Hospital acquiredcases in Patients
Hospital personnel cases
Cases diagnosed(inpatients and outpatients)
Cases hospitalized
Public Hospital of Marseilles (All departments)
9 100 1046 262
Pediatric Emergency rooms / 2 512 /
Adult Emergency rooms / 19 190 /
Infectious Diseases department
1 0 210 57
Medical departments but infectious diseases department
7 21 / 41
Pediatric departments 1 15 / 136
Intensive Care Unit 0 3 35 35
Gynaecology‐Obstetrics 1 4 57 11
Hospital acquired Influenza in HCP
• Only 2 HAI cases were reported for both ID and PER while they cared for 75% of patients
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
Take home messages
• We are poor lonesome cowboys and we are a long long way from home– Training and organizing emergency rooms of the hospitals
– Discussing mandatory vaccination of HCP when possible
– Improving technical features and training in our referral centers with using the EuroNHID survey as basis for implementation
34
ESCMID O
nline
Lectu
re Lib
rary
© by au
thor
35
Authors and contributors (in alphabetic order):
•Barbara Bannister (Steering Committee member, Royal Free Hospital, Infection & Immunity Division, London, United Kingdom);•Hans-Reinhard Brodt (Steering Committee member, Klinikum der Johann Wolfgang Goethe Universitaet, Med Klinik III/ Infektiologie, Frankfurt, Germany);•Philippe Brouqui (Steering Committee member, Assistance Publique des Hopitaux de Marseille, France);•Giuseppina De Iaco (Project Coordinator, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani, Rome, Italy); •Francesco M. Fusco (Project Coordinator, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani, Rome, Italy);•René Gottschalk (Steering Committee member, Office of Public Health, Frankfurt, Germany);•Giuseppe Ippolito (Project Leader, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani, Rome, Italy);•Helena C. Maltezou (Steering Committee member, Hellenic Centre for Infectious Disease Control, Athens, Greece);•Simone Lanini, (Project collaborator, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani, Rome, Italy);•Vincenzo Puro (Scientific Project Coordinator, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani, Rome, Italy); •Stefan Schilling (Steering Committee member, Klinikum der Johann Wolfgang Goethe Universitaet, Med Klinik III/ Infektiologie, Frankfurt, Germany);•Gail Thomson (Steering Committee member, Health Protection Agency, England).Other EuroNHID partners:
-Norbert Vetter, Project partner, Otto Wagner Spital, Interne Lungenabteilung, Vienna, Austria;-Mira Kojouharova, Project patner, National Centre for Infectious and Parasitic Diseases, Sofia, Bulgaria;-Kremena Parmakova, Project collaborator, National Centre for Infectious and Parasitic Diseases, Sofia, Bulgaria;-Peter Skinhoj, Project partner, Epidemiklinikken Rigshospitalet, Copenhagen, Denmark;-Heli Siikamaki, Project partner, Central Hospital, Helsinki University, Division Infectious Diseases, Aurora Hospital, Helsinki, Finland;-Christian Perronne, Project partner, Hospital Pitié-Salpetrière, Service de Maladies Infectieuses et Tropicales, Paris, France;-Olga Adrami, Project collaborator, Hellenic Centre for Infectious Disease Control, Athens, Greece;-John Lambert, Project partner, University College of Dublin, Mater Misericordiae Hospital, Dublin, Republic of Ireland;-Robert Hemmer, Project partner, National Service of Infectious Diseases, Centre Hospitalier de Luxembourg, Luxembourg;-Michael Borg, Project partner, Saint Luke’s Hospital, Malta;-Andrzej Horban, Project partner, Hospital of Infectious Diseases, Warsaw, Poland;-Josef Higersberger, Project collaborator, Hospital of Infectious Diseases, Warsaw, Poland;-Janusz Stanczak, Project collaborator, Hospital of Infectious Diseases, Warsaw, Poland;-Franc Strle, Project partner, University Medical Centre, Ljubljana, Slovenia;-Antoni Trilla, Project partner, Hospital Clinic Universitat de Barcelona, Unitat de Suport i Prevencio', Barcelona, Spain
Other EuroNHID staff:-Ramona Iacovino, Administrative Support, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani, Rome, Italy;-Fabrizio La Trofa, Technical Support, Istituto Nazionale per le Malattie Infettive, Lazzaro Spallanzani, Rome, Italy.ESCMID
Onli
ne Le
cture
Librar
y
© by au
thor